Opioid Indicator Spray for Complex Surfaces
Award amount
$167,446Program and phase
STTR · Phase IAward year
2021Award details
- Awarding agency
- Department of Defense
- Branch
- Office for Chemical and Biological Defense
- Recipient company
- Clear Scientific, LLC
- Proposal award date
- 2021-01-08
- Contract end date
- 2021-06-07
- UEI
- USCME5Z4GVN7
- Solicitation number
- 20.A
- Topic code
- CBD20A-T001
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- A Novel Reversal Agent for Treatment of Overdose from the Combination of Fentanyl and Xylazine
- Stable Antimicrobial Formulation of Scopolamine for Multi-dose Vial
- Stable Antimicrobial Formulation of Scopolamine for Multi-dose Vial
- An oral therapeutic to treat intoxication by prescription and illicit stimulants
- Dual Formulation of Atropine/Scopolamine with Enhanced Stability
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Eye-readable Solution-based Dye Displacement Probe for Large-area Detection of Opioids
- Large Area Opioid Identification by Bioengineered Broad-Spectrum Receptors
- Spray-based visual indicator of opioids for the rapid and effective decontamination of large areas
Research funding history
19 SBIR/STTR records share this UEI (2017–2024). Reported award amounts total $10,849,675. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, Department of Health and Human Services